Clinical Trial

Reinforced Pancreaticojejunostomy With or Without glubran2

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 16, 2026 (before its estimated April 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula by enforce pancreaticojejunostomy with tissue glue .
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2024-12-24; most recent amendment 2026-03-13.
Status change: Not Yet Recruiting → Recruiting 2025-01-03
Trial Details
NCT Number NCT06756074
Lead Sponsor Minia University
Conditions Pancreatic Fistula, Pancreas Cancer, Periampullary Carcinoma, Pancreatic Ductal Adenocarcinoma
Enrollment 100 participants
Start Date 2025-01-15
Primary Completion 2026-04-15 (estimated)
Study Completion 2026-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-16